A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors

Clinical trial NCT06598007 · RECRUITING

Trial details

NCT number: NCT06598007
Sponsor: Crossignal Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult Colorectal Cancer Pancreatic Ductal Adenocarcinoma

Start date: 2024-09-20
Primary completion: 2027-06-20
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.